MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Search

Moleculin Biotech Inc

Cerrado

0.46

Resumen

Variación precio

24h

Actual

Mínimo

0.45

Máximo

0.48

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+1319.15% upside

Moleculin Biotech Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

13 oct 2025, 21:45 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13 oct 2025, 21:07 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13 oct 2025, 17:03 UTC

Principales Movimientos del Mercado

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13 oct 2025, 23:53 UTC

Charlas de Mercado

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13 oct 2025, 23:39 UTC

Charlas de Mercado

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 22:15 UTC

Charlas de Mercado

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13 oct 2025, 21:57 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

13 oct 2025, 21:36 UTC

Charlas de Mercado

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13 oct 2025, 21:30 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13 oct 2025, 21:06 UTC

Adquisiciones, fusiones, absorciones

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct 2025, 20:52 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13 oct 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

13 oct 2025, 20:35 UTC

Adquisiciones, fusiones, absorciones

Goldman Expects to Close Deal in 1Q

13 oct 2025, 20:34 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13 oct 2025, 20:33 UTC

Adquisiciones, fusiones, absorciones

Industry Ventures Currently Manages $7B of Assets Under Supervision

13 oct 2025, 20:32 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13 oct 2025, 20:31 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13 oct 2025, 20:29 UTC

Adquisiciones, fusiones, absorciones

Goldman Sachs to Buy VC Firm Industry Ventures

13 oct 2025, 19:05 UTC

Charlas de Mercado

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13 oct 2025, 18:59 UTC

Charlas de Mercado

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13 oct 2025, 18:26 UTC

Charlas de Mercado

Precious Metals Close at New Record Highs -- Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 18:10 UTC

Charlas de Mercado

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

13 oct 2025, 17:05 UTC

Charlas de Mercado

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13 oct 2025, 16:03 UTC

Adquisiciones, fusiones, absorciones

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13 oct 2025, 15:35 UTC

Charlas de Mercado

Precious Metals Push Record Highs Further -- Market Talk

Comparación entre iguales

Cambio de precio

Moleculin Biotech Inc previsión

Precio Objetivo

By TipRanks

1319.15% repunte

Estimación a 12 Meses

Media 6.67 USD  1319.15%

Máximo 12 USD

Mínimo 4 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Moleculin Biotech Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

3

Comprar

0

Mantener

0

Vender

Finanzas

$

help-icon Live chat